Corporate
  • bioMérieux

    Created in 1963
  • Social networks

    1,684 310,295
  • Sectors

  • Location

    100 All. Louis Raymond, 69280 Marcy-l'Étoile, France

    Marcy-l'Étoile

    France

  • Engaged entities

    247
    181 48
  • Added in Motherbase

    18 Sep 2019, 4:49 p.m.
Description
  • Value proposition

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP


    in vitro diagnostics, infectious diseases, reagents, automated instruments, medical analysis, cosmetics, pharmaceutical, industries, healthcare associated infections, molecular biology, microbiology, immunoassays, antimicrobial stewardship, rapid diagnostics, food safety, veterinary diagnostics, blood bank, and sepsis

  • Original language

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP

Entity interactions BETA
Entity TypeTweets Articles
Université Grenoble Alpes Université Grenoble Alpes
Higher Education, edtech
Other

5 Feb 2024


French Embassy in Canada French Embassy in Canada
Government Administration
Other

3 May 2023


Fondation Entreprendre Fondation Entreprendre
entrepreneurship, Non-profit Organizations
Other

13 Dec 2023


Tout Lyon Tout Lyon
Online Audio and Video Media
Other

24 Jun 2023


ALTITUD RH | Marque Employeur & Management ALTITUD RH | Marque Employeur & Management
HRtech, Consulting, Human Resources Services
Not capitalistic
Not partnership
Event

17 Nov 2022


Sepsis Alliance Sepsis Alliance
healthtech, Non-profit Organizations
Other

25 Apr 2023


Fondation Mérieux Fondation Mérieux
healthtech, Non-profit Organizations
Other

7 Nov 2023


International Association for Food Protection International Association for Food Protection
foodtech, Food and Beverage Services
Other

1 Aug 2022


The UK Sepsis Trust The UK Sepsis Trust
fintech, edtech, healthtech, Hospitals and Health Care
Other

1 Sep 2023


Hospices Civils de Lyon - HCL Hospices Civils de Lyon - HCL
Hospitals and Health Care
Other

22 Nov 2022


Radars
Loading...